• Citer

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial

par Retèl, Valesca V.P.;Byng, Danalyn;Linn, Sabine S.C.;Jóźwiak, Katarzyna;Koffijberg, Hendrik;Rutgers, Emiel Th;Cardoso, Fatima ;Piccart-Gebhart, Martine ;Poncet, Coralie;Van't Veer, Laura;Van Harten, Wim
Référence European journal of cancer, 137, page (193-203)
Publication Publié, 2020-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
Auteur:	Retèl, Valesca V.P.; Byng, Danalyn; Linn, Sabine S.C.; Jóźwiak, Katarzyna; Koffijberg, Hendrik; Rutgers, Emiel Th; Cardoso, Fatima; Piccart-Gebhart, Martine; Poncet, Coralie; Van't Veer, Laura; Van Harten, Wim
Informations sur la publication:	European journal of cancer, 137, page (193-203)
Statut de publication:	Publié, 2020-09
Sujet CREF:	Cancérologie
Mots-clés:	70-gene signature
	Breast cancer
	Cost-effectiveness
	Gene expression profiling
	MammaPrint®
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2020.07.002
	info:pii/S0959804920303816
	info:scp/85089245218
	info:pmid/32795875